Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults

NCT01479296 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: VRC rAd5 vaccine (rAd5 gag-pol/env A/B/C)
BIOLOGICAL: rAd5 env A
BIOLOGICAL: rAd5 env B
BIOLOGICAL: rAd5 env C
BIOLOGICAL: rAd5 gag-pol
BIOLOGICAL: Placebo Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)